Vireo Growth (VREOF) Work In Process (2020 - 2026)
Vireo Growth (VREOF) reported Work In Process of $32.3 million for Q1 2026, up 127.75% on a YoY basis from $14.2 million in Q1 2025, and up 4.19% sequentially from $31.0 million in Q4 2025.
Vireo Growth (VREOF) Work In Process (2020 - 2026) Analysis & Trends
Vireo Growth (VREOF) has 7 years of Work In Process data on file, last reported at $32.3 million in Q1 2026.
- For the quarter ending Q1 2026, Work In Process rose 127.75% year-over-year to $32.3 million; the trailing twelve-month figure through Mar 2026 stood at $32.3 million (up 127.75% YoY), and the FY2025 full-year result was $31.0 million, up 123.68% from the prior year.
- Work In Process grew to $32.3 million in Q1 2026, from $31.0 million in the prior quarter.
- In the past five years, Work In Process ranged from a high of $32.3 million in Q1 2026 to a low of $12.8 million in Q3 2023.
- A 5-year average of $17.5 million and a median of $14.1 million in 2023 frame the typical range for Work In Process.
- Across the five-year window, Work In Process dropped 13.59% in 2024 and soared 128.69% in 2025, its largest moves.
- Tracing VREOF's Work In Process over 5 years: stood at $14.2 million in 2022, then retreated by 8.1% to $13.1 million in 2023, then advanced by 6.13% to $13.9 million in 2024, then surged by 123.68% to $31.0 million in 2025, then grew by 4.19% to $32.3 million in 2026.
- Business Quant data shows VREOF's Work In Process at $32.3 million in Q1 2026, $31.0 million in Q4 2025, and $30.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.30 Mn |
| Dec 31, 2025 | 31.00 Mn |
| Sep 30, 2025 | 30.00 Mn |
| Jun 30, 2025 | 26.80 Mn |
| Mar 31, 2025 | 14.18 Mn |
| Dec 31, 2024 | 13.86 Mn |
| Sep 30, 2024 | 13.12 Mn |
| Jun 30, 2024 | 13.19 Mn |
| Mar 31, 2024 | 13.15 Mn |
| Dec 31, 2023 | 13.06 Mn |
| Sep 30, 2023 | 12.78 Mn |
| Jun 30, 2023 | 14.08 Mn |
| Mar 31, 2023 | 15.22 Mn |
| Dec 31, 2022 | 14.21 Mn |
| Sep 30, 2022 | 14.35 Mn |
| Jun 30, 2022 | 12.96 Mn |
| Mar 31, 2022 | 12.81 Mn |
| Dec 31, 2021 | 15.17 Mn |
| Sep 30, 2021 | 14.72 Mn |
| Jun 30, 2021 | 11.41 Mn |